Evidence map›Paper›PMID 37737664›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2023

The Lysosomal Calcium Channel TRPML1 Maintains Mitochondrial Fitness in NK Cells through Interorganelle Cross-Talk.

Dennis Clement, Edina K Szabo, Silje Zandstra Krokeide, Merete Thune Wiiger, Marianna Vincenti, Daniel Palacios, Young-Tae Chang, Christian Grimm, Sandip Patel, Harald Stenmark and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. HKDC1, a target of TFEB, is essential to maintain both mitochondrial and lysosomal homeostasis, preventing cellular senescence.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 7 countries.

Dennis ClementPrecision Immunotherapy Alliance, Institute for Cancer Research, University of Oslo, Norway.
Edina K SzaboPrecision Immunotherapy Alliance, Institute for Cancer Research, University of Oslo, Norway.ORCID 0000-0003-4780-5458
Silje Zandstra KrokeidePrecision Immunotherapy Alliance, Institute for Cancer Research, University of Oslo, Norway.ORCID 0009-0002-3466-8706
Merete Thune WiigerDepartment of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
Marianna VincentiPrecision Immunotherapy Alliance, Institute for Cancer Research, University of Oslo, Norway.ORCID 0000-0001-5361-0185
Daniel PalaciosPrecision Immunotherapy Alliance, Institute for Cancer Research, University of Oslo, Norway.ORCID 0009-0008-8516-6304
Young-Tae ChangDepartment of Chemistry, Pohang University of Science and Technology, Pohang, Republic of Korea.ORCID 0000-0002-1927-3688
Christian GrimmDepartment of Pharmacology and Toxicology, Faculty of Medicine, University of Munich, Munich, Germany.
Sandip PatelDepartment of Cell and Developmental Biology, University College London, London, United Kingdom.
Harald StenmarkDepartment of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Oslo, Norway.
Andreas BrechDepartment of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Oslo, Norway.
Rakesh Kumar MajhiPrecision Immunotherapy Alliance, Institute for Cancer Research, University of Oslo, Norway.
Karl-Johan MalmbergPrecision Immunotherapy Alliance, Institute for Cancer Research, University of Oslo, Norway.ORCID 0000-0002-8718-9373
Oslo University Hospital · NOUniversity of Oslo · NOMRC Laboratory for Molecular Cell Biology · GBMünchen Klinik · DEPohang University of Science and Technology · KR

Funding

Therapeutic Potential of Adaptive NK Cells in Cancer and TransplantationP01CA111412 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MILLER, JEFFREY S. · 2005 to 2025
$38.2M
NCI NIH HHS P01 CA111412
6 · The paper itself

Abstract

Cytotoxic lymphocytes eliminate cancer cells through the release of lytic granules, a specialized form of secretory lysosomes. This compartment is part of the pleomorphic endolysosomal system and is distinguished by its highly dynamic Ca2+ signaling machinery. Several transient receptor potential (TRP) calcium channels play essential roles in endolysosomal Ca2+ signaling and ensure the proper function of these organelles. In this study, we examined the role of TRPML1 (TRP cation channel, mucolipin subfamily, member 1) in regulating the homeostasis of secretory lysosomes and their cross-talk with mitochondria in human NK cells. We found that genetic deletion of TRPML1, which localizes to lysosomes in NK cells, led to mitochondrial fragmentation with evidence of collapsed mitochondrial cristae. Consequently, TRPML1-/- NK92 (NK92ML1-/-) displayed loss of mitochondrial membrane potential, increased reactive oxygen species stress, reduced ATP production, and compromised respiratory capacity. Using sensitive organelle-specific probes, we observed that mitochondria in NK92ML1-/- cells exhibited evidence of Ca2+ overload. Moreover, pharmacological activation of the TRPML1 channel in primary NK cells resulted in upregulation of LC3-II, whereas genetic deletion impeded autophagic flux and increased accumulation of dysfunctional mitochondria. Thus, TRPML1 impacts autophagy and clearance of damaged mitochondria. Taken together, these results suggest that an intimate interorganelle communication in NK cells is orchestrated by the lysosomal Ca2+ channel TRPML1.

Indexed as

Calcium ChannelsTransient Receptor Potential ChannelsCalciumHumansKiller Cells, NaturalLysosomesMitochondriaCalciumCalcium ChannelsTransient Receptor Potential Channels

Identifiers

PMID37737664
PMCPMC10579149
OpenAlexW4386944903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.